Triptaanit

Triptaanit is a term that may refer to the class of drugs known as triptans, used to treat acute migraine attacks, depending on language and context. Triptans are selective serotonin (5-HT1B/1D) receptor agonists that cause cranial vasoconstriction and inhibit release of neuropeptides involved in migraine. Common agents include sumatriptan, rizatriptan, zolmitriptan, eletriptan, and naratriptan. They are typically administered orally, though nasal spray or subcutaneous forms are available for rapid relief. Onset is usually within 30 to 60 minutes, and efficacy varies among individuals.

Triptans are prescription medicines in many countries and are intended for adults with moderate to severe migraine with or without aura. They are not used for prevention. Contraindications include coronary artery disease, uncontrolled hypertension, a history of stroke or transient ischemic attack, and certain other cardiovascular risk factors. Possible side effects include dizziness, tingling, flushing, and chest pressure; rare adverse events can include hypertension and, when combined with other serotonergic drugs, serotonin syndrome.

In other contexts, triptaanit might appear as a misspelling or as a fictional term; if you intended a different subject, please provide more detail.